The genetic ablation of ATG5 and ATG7 has been reported to spontaneously induce the development of liver cancer through the accumulation of p62/SQSTM1-driven nuclear factor erythroid-2-related factor 2 (Nrf2) and induction of antioxidant responses [450,451]. Here, SQSTM1 is linked to liver cancer.